Background: The specific aim of our study was neither prognosis nor long-term evaluation but focus on determining incidence of rheumatoid nodules (RN) in a large population of patients with rheumatoid arthritis (RA) on the coastline of Croatia (Dalmatia) within a certain range. We compared our data with those published previously in the literature.
Methods: Our study was focused on determining incidence of RN occurrence in patients with rheumatoid arthritis in Dalmatia, Croatia by comparing these figures with data reported elsewhere and evaluating its importance in the process of diagnosing RA. The duration of the study was 10 years (1991-2001). There were 421 patients (344 women and 77 men) with confirmed RA diagnosis. Median follow-up time was 2 years (range: 1.4-3.5 years).
Results: Existence of RN was established by clinical examination in 109 of 421 patients; incidence density was 17.3%. RN occurred somewhat more frequently in men (32%) as compared to women (24%) without statistically significant difference. In 38% of patients, RN occurred simultaneously in several sites, more frequently in men (64%) than in women (30%) (odds ratio [OR] 2.13, p <0.05). Correlation of seropositivity and RN appearance was very high: positive in 84% of patients with nodules as compared to 58% of patients without nodules (OR 1.45, p <0.05) with no statistically significant differences between sexes.
Conclusions: Results obtained warrant the conclusion that RN incidence in our patients from Dalmatia is comparable with results of earlier Croatian studies as well as with Western European figures and Caucasian population data reported on other continents. RN incidence differs significantly for Asian and Arabian populations, i.e., is less frequent, and for the U.S. population, where it is more frequent.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0188-4409(02)00456-3 | DOI Listing |
JAMA
January 2025
CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy.
Importance: Essential thrombocythemia, a clonal myeloproliferative neoplasm with excessive platelet production, is associated with an increased risk of thrombosis and bleeding. The annual incidence rate of essential thrombocythemia in the US is 1.5/100 000 persons.
View Article and Find Full Text PDFJ Intern Med
January 2025
School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
Background: Evolving evidence suggests that patients undergoing treatment with Janus kinase inhibitors (JAKi) may face an increased risk of cardiovascular events, malignancies, and serious infections.
Objectives: We assessed cardiovascular, malignancy, and serious infection risks associated with JAKi use compared to tumor necrosis factor inhibitor (TNFi) use, which served as the active comparator, in patients with rheumatoid arthritis (RA) or ulcerative colitis (UC).
Methods: This study emulated a target trial using South Korea's nationwide claims database (2013-2023).
Front Mol Neurosci
January 2025
Neurology Clinic, Military Institute of Medicine- National Research Institute, Warsaw, Poland.
Multiple sclerosis (MS) is a chronic central nervous system (CNS) disease with demyelinating inflammatory characteristics. It is the most common nontraumatic and disabling disease affecting young adults. The incidence and prevalence of MS have been increasing.
View Article and Find Full Text PDFZhonghua Nei Ke Za Zhi
February 2025
Department of Rheumatology, the First Affiliated Hospital of Harbin Medical University, Harbin150001, China.
Using the Global Burden of Disease Study 2019 (GBD 2019) database, the Joinpoint regression model was used to analyze the trend of rheumatoid arthritis (RA) incidence and the standardized disability-adjusted life years (DALY) rate in China. The age, period, and cohort effects were discussed based on the age-period-cohort model. The grey prediction model GM (1, 1) was used to fit the trend of incidence and the standardized DALY rate of RA and predict the incidence and standardized DALY rate of RA in China from 2020 to 2034.
View Article and Find Full Text PDFRMD Open
January 2025
Epidemiology and Health Services Research, German Rheumatology Research Center, Berlin, Germany.
Objective: To analyse work participation among patients with inflammatory rheumatic musculoskeletal diseases (iRMDs), namely rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), systemic lupus erythematosus (SLE), systemic sclerosis (SSc) and ANCA-associated vasculitis (AAV).
Methods: A cross-sectional sample of 16 421 patients from the National Database of the German Collaborative Arthritis Centers, aged <65 years were analysed. For each diagnosis, yearly rates of absenteeism, employment and disability pensions were analysed from 2010 to 2022.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!